{"id":"tp-56911","type":"article-newspaper","title":"EMA Panel Recommends Expanded Use of Merck’s Enflonsia in Europe","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/56911","datePublished":"2026-11-13T17:21:12.000Z","dateModified":"2026-11-13T17:21:12.000Z","language":"en","abstract":"The Committee for Medicinal Products for Human Use backed a broader indication for the RSV prevention treatment, whose active ingredient is clesrovimab.","section":"Regulation","references":[]}